IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 137 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for
Recalled March 1, 2023 · FDA recall D-0343-2023 · IBSA PHARMA
Hazard
Subpotent Drug · FDA Class II
Units
N/A
Sold at
Nationwide in the USA.
Description
Subpotent Drug
Product
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 137 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0145-5
Manufacturer(s)
IBSA PHARMA INC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →